Many patients still have doubts about the digital processing and storage of their medical data, with concerns about doctor-patient confidentiality, privacy, ethics, and safety. Studies* conducted by Patient View have shown that only a small percentage of patients are willing to share their data with pharmaceutical and medical devices companies.
One goal is therefore to increase patient trust in both new information technologies and manufacturers themselves. But for this to happen, companies have to take a sincere, thorough interest in the needs and wants of their consumers, or patients.
Gaining the long-term trust of patients in digital medical solutions requires managing expectations pragmatically and ensuring transparency. At this point of time, we should not claim or imply that AI, smart data or similar technologies will replace doctors who possess expertise and a capacity for human empathy. Doctors will continue to play a central role in the patient’s journey and provide emotional support.
That’s why we talk about Augmented Intelligence: The benefits of artificial intelligence complement human qualities and capabilities in order to achieve better health outcomes for patients. Augmented intelligence reduces the incidence of misdiagnosis and offers more useful insights – quickly, accurately, easily and without losing the human element.
We integrate doctors and consumers into the process at an early stage and throughout the entire value chain, regardless of the pharmaceutical manufacturers and medical devices companies involved in each specific area.
We are a service provider focusing on innovative projects to offer medical professionals better ways to communicate with patients and offer holistic diagnoses. This in turn improves interaction between medical professionals and patients.
Everything revolves around the doctor and patient – and not the technology. Nevertheless, we believe that technology is the key to building better doctor-patient relationships, which is why we have adopted the lean start-up method for our innovative projects: quick, agile, and low-risk. Creating a space for highly focused work and effective innovation soon brings competitive advantages within reach. This enables us to identify the needs of stakeholders early on and intervene if we have to, eliminating time-consuming, costly processes.
*(on behalf of Deloitte) and KMPG
Head of Life Sciences
+41 31 561 3946
Chief Data Scientist
+41 79 679 86 84
+41 43 216 6456
Business Solution Manager
+41 43 216 6886
+41 43 216 6588
How do we make meaningful use of AI technology in the healthcare sector? How will it impact society? Are we looking at small advances or major disruption? Stephan Sigrist, founding head of the W.I.R.E think tank and Daniel Diezi, Head of Life Sciences & MedTech at Zühlke, got together to discuss these and other questions.